health

Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers

By
1 Mins read
51
0
Share
Reading Time: < 1 minute

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s (Alamy/PA) -

Drugs that are said to slow the progression of Alzheimer’s disease “make no meaningful difference to patients” while increasing the risk of swelling and bleeding  Read More

51
0
Share
Related posts
health

Tate brothers referred to counter-terror police over Russia trip

By
1 Mins read
Reading Time: < 1 minuteThe Tate brothers have been referred to counter-terror police after they visited Russia and participated in military training exercises. Read More
health

UN staffers held in Afghanistan are released by Taliban

By
1 Mins read
Reading Time: < 1 minuteTwo United Nations staff members detained by the Taliban in the western Afghan city of Herat on 9 August have been released…
health

Police bust a counterfeit cancer drug racket in India

By
1 Mins read
Reading Time: < 1 minutePolice in India’s capital of Delhi busted a multi-city racket trafficking counterfeit and illegally diverted anti-cancer drugs, arrested 17 people, and seized…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.